Standing Neurophysiological Assessment of Lower Extremity Muscles Post-Stroke
July 26th, 2021
2.3K views
This protocol describes the process for performing a neurophysiological assessment of the lower extremity muscles, tibialis anterior and soleus, in a standing position using TMS in people post-stroke. This position provides a greater probability of eliciting a post-stroke TMS response and allows for the use of reduced stimulator power during neurophysiological assessments.
Overview
This protocol allows for the neurophysiologic assessment of the lower extremity corticospinal tract post-stroke when gait and balance are of primary interest. The technique increases the probability of eliciting a motor evoked potential in individuals who may not show a resting response.
Key Study Components
Area of Science
- Neurophysiology
- Stroke Rehabilitation
- Motor Control
Background
- Assessment of lower extremity muscles is crucial for post-stroke recovery.
- Transcranial magnetic stimulation (TMS) is a non-invasive method used to evaluate corticospinal tract function.
- Standing position during assessment enhances response probability.
- Many post-stroke patients do not exhibit a resting response, complicating assessments.
Purpose of Study
- To evaluate neurophysiological responses in lower extremity muscles.
- To improve assessment techniques for post-stroke patients.
- To facilitate better understanding of gait and balance issues.
Methods Used
- Visual inspection of signal quality after electrode attachment.
- Use of elastic bandages to minimize electrode movement.
- Calibration of dual top force plate for data collection.
- Implementation of TMS to assess motor evoked potentials.
Main Results
- Increased likelihood of eliciting motor evoked potentials.
- Successful assessment of corticospinal tract function in standing position.
- Method applicable to various neurological populations.
- Enhanced understanding of neurophysiology related to gait and balance.
Conclusions
- The protocol is effective for assessing lower extremity neurophysiology post-stroke.
- Standing position during TMS improves assessment outcomes.
- This method can be adapted for other neurological conditions.
Frequently Asked Questions
What is the main advantage of this TMS protocol?
The main advantage is the increased probability of eliciting a motor evoked potential in post-stroke patients.
Can this method be used for other neurological populations?
Yes, it can be applied to any neurological population interested in corticospinal tract neurophysiology.
How is signal quality ensured during the assessment?
Signal quality is visually inspected after attaching electrodes and secured with elastic bandages.
What is the significance of using a standing position?
A standing position enhances the likelihood of eliciting a post-stroke TMS response.
What are the key components of the assessment method?
Key components include electrode placement, signal quality inspection, and TMS calibration.
What outcomes can be expected from this protocol?
Expected outcomes include improved understanding of motor control and balance in post-stroke patients.
Executive Industry Relevance
Standing TMS-based neurophysiological assessment of lower extremity muscles post-stroke addresses a critical gap in evaluating motor circuit function relevant to gait and balance. This protocol enhances predictive confidence in target validation for neurorehabilitation interventions by enabling reliable measurement of corticomotor responses in populations with limited resting responses. The approach supports risk-adjusted advancement decisions in early discovery and translational research for post-stroke motor recovery.
Strategic Applications in Biopharma R&D
Early Discovery & Target Validation
- Enables interrogation of corticospinal tract function in disease-relevant, weight-bearing states.
- Supports biological de-risking by increasing the probability of eliciting measurable motor evoked potentials (MEPs).
- Facilitates functional target validation for interventions aimed at postural and gait impairments.
- Improves predictive confidence for portfolio triage in neurorehabilitation research.
Screening & Assay Development
- Standardizes lower extremity TMS procedures for reproducible, quantitative assessment of corticomotor responses.
- Prepares validated neuromuscular systems for downstream screening of therapeutic candidates.
- Enables reliable comparison of stimulation thresholds and MEP amplitudes across conditions.
- Supports assay scalability and platform reuse in neurophysiological studies.
Translational & Preclinical Research
- Aligns assessment conditions with functional states relevant to gait and balance, enhancing translational biomarker value.
- Provides continuity from discovery-stage neurophysiology to preclinical validation of motor recovery strategies.
- Reduces mechanistic ambiguity in evaluating intervention effects on lower extremity motor circuits.
Pipeline & Workflow Integration
This protocol integrates into the discovery-to-preclinical continuum for neurorehabilitation, bridging early target validation with translational research on gait and balance recovery.
- Discovery Biology: Supports hypothesis testing and pathway clarification for corticospinal tract involvement in post-stroke motor deficits.
- Screening: Delivers reproducible, quantitative MEP outputs for cross-condition and cross-population comparison.
- Analytics: Provides threshold and amplitude measurements to inform statistical analysis and decision-making.
- Translational Research: Aligns neuromuscular assessment with functional endpoints relevant to clinical recovery.
- Enterprise Reuse: Establishes a standardized, reusable protocol for lower extremity neurophysiological assessment in diverse neurological populations.
Operational & Enterprise Impact
- Scientific Value: Increases predictive confidence and reduces mechanistic ambiguity in lower extremity target validation.
- Operational Value: Enhances standardization, reproducibility, and scalability of neurophysiological assessments.
- Strategic Value: Informs go/no-go decisions and capital allocation for neurorehabilitation portfolios.
- Portfolio Impact: Supports risk-adjusted prioritization and advancement of motor recovery interventions.
Implementation Considerations
- Requires expertise in TMS application, sEMG signal acquisition, and neurophysiological data analysis.
- Needs dual-top force plates, image guidance, and TMS instrumentation for accurate and reproducible assessments.
- Demands cross-team standardization of electrode placement, stimulation parameters, and data interpretation.
- Adaptation may be necessary for different neurological populations or model systems.
- Practical limitations include participant fatigue and the need for safety measures during standing assessments.
Biopharma FAQs
Why does null hypothesis testing matter for TMS MEP target validation?
Null hypothesis testing in TMS MEP assessments enables objective evaluation of whether observed corticomotor responses differ from baseline or control conditions, supporting rigorous target validation for lower extremity interventions post-stroke.
How does independent variable isolation fit the standing TMS discovery pipeline?
Isolating stimulation intensity and grid location as independent variables allows precise mapping of corticomotor responses, clarifying the relationship between stimulation parameters and muscle activation in the discovery pipeline.
What do quantitative dependent variable measurements enable in this protocol?
Quantitative measurements of MEP amplitude and motor threshold provide reproducible outputs for comparing intervention effects and tracking neurophysiological changes across conditions and timepoints.
Why are replication requirements critical for cross-functional TMS collaboration?
Replication of TMS MEP assessments ensures data reliability and comparability across research teams, facilitating cross-functional collaboration and integration of findings into broader neurorehabilitation programs.
What statistical analysis capabilities are required before implementing TMS MEP assessments?
Robust statistical analysis is needed to interpret MEP amplitude distributions, threshold variability, and condition effects, ensuring that implementation decisions are grounded in reproducible and meaningful neurophysiological data.
